PTCL

Clinical trials for PTCL explained in plain language.

Never miss a new study

Get alerted when new PTCL trials appear

Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New cancer drug enters human testing for Tough-to-Treat cancers

Disease control Completed

This early-stage study tested a new drug called PTX-100 in 25 patients with advanced cancers that had stopped responding to standard treatments. The main goals were to check the drug's safety, how the body processes it, and its initial effects on cancer-related proteins. Patients…

Matched conditions: PTCL

Phase: PHASE1 • Sponsor: Prescient Therapeutics, Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

PTCL

Get alerted when new PTCL trials appear

New cancer drug enters human testing for Tough-to-Treat cancers